West Pharmaceutical Services WST Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's total cost of revenue?
- West Pharmaceutical Services (WST) reported total cost of revenue of $548.5M in Q1 2026.
- How has West Pharmaceutical Services's total cost of revenue changed year-over-year?
- West Pharmaceutical Services's total cost of revenue increased by 17.7% year-over-year, from $466.1M to $548.5M.
- What is the long-term trend for West Pharmaceutical Services's total cost of revenue?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's total cost of revenue has grown at a 4.4% compound annual growth rate (CAGR), from $1.66B to $1.97B.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.